Clinical Trial Update: Therapeutic Virtual Reality : Impact on the Management of Pain and Anxiety Related to Hematology Care (REVEH) [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 trial evaluating Therapeutic Virtual Reality for managing pain and anxiety in hematology care has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Neoplasms

Drugs mentioned

• Therapeutic Virtual Reality

Snippet

Sponsor: Weprom | Conditions: Hematologic Neoplasms | Phase 2, Phase 3 | Status: COMPLETED